Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × birinapant × Clear all

NCT02756130 2025-05-13

Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)

Phase 1/2 Withdrawn

Fallopian Tube Neoplasms, Ovarian Neoplasms